Evidence map›Paper›PMID 23614709›Full record

ArticleJournal of the American Chemical Society2013

Sub-nanomolar detection of prostate-specific membrane antigen in synthetic urine by synergistic, dual-ligand phage.

Kritika Mohan, Keith C Donavan, Jessica A Arter, Reginald M Penner, Gregory A Weiss

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Journal of the American Chemical Society, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02957370 (Electro-Phage and Colorimetric Aptamer Sensors for Clinical Staging and Monitoring of Bladder Cancer), which is not on this map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02957370 unknown statusnot on this mapstarted 2015, after this paper: background citation

Electro-Phage and Colorimetric Aptamer Sensors for Clinical Staging and Monitoring of Bladder Cancer

TypeobservationalSponsorUniversity of California, IrvineRan2015 to 2022Enrolled230ConditionsUrinary Bladder Neoplasms
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Urine-derived exosomal PSMA is a promising diagnostic biomarker for the detection of prostate cancer on initial biopsy.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2023
    Article
  3. Properties of a NovelFoods (Basel, Switzerland) · 2022
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Bioinspired Assemblies and Plasmonic Interfaces for Electrochemical Biosensing.Journal of electroanalytical chemistry (Lausanne, Switzerland) · 2016
    Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Biosensing with Virus Electrode Hybrids.Current protocols in chemical biology · 2015
    Article
  16. Review
  17. Diagnosis of prostate cancer via nanotechnological approach.International journal of nanomedicine · 2015
    Review
  18. Virus outbreaks in chemical and biological sensors.Sensors (Basel, Switzerland) · 2014
    Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Kritika MohanDepartment of Chemistry, University of California, Irvine, California 92697-2025, USA.
Keith C Donavan
Jessica A Arter
Reginald M Penner
Gregory A Weiss
University of California, Irvine · US

Funding

Single Molecule Enzymology with Carbon NanocircuitsR01CA133592 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI WEISS, GREGORY A. · 2008 to 2012
$1.2M
Virus Electrodes for Fungal Pathogen DetectionR43AI074163 · NIAID · MOLECULAR EXPRESS, INC. · PI FUJII, GARY · 2008 to 2009
$362k
NCI NIH HHS R01 CA133592NCI NIH HHS R01 CA133592-01NIAID NIH HHS 1 R43 AI074163NIAID NIH HHS R43 AI074163
6 · The paper itself

Abstract

The sensitive detection of cancer biomarkers in urine could revolutionize cancer diagnosis and treatment. Such detectors must be inexpensive, easy to interpret, and sensitive. This report describes a bioaffinity matrix of viruses integrated into PEDOT films for electrochemical sensing of prostate-specific membrane antigen (PSMA), a prostate cancer biomarker. High sensitivity to PSMA resulted from synergistic action by two different ligands to PSMA on the same phage particle. One ligand was genetically encoded, and the secondary recognition ligand was chemically synthesized to wrap around the phage. The dual ligands result in a bidentate binder with high-copy, dense ligand display for enhanced PSMA detection through a chelate-based avidity effect. Biosensing with virus-PEDOT films provides a 100 pM limit of detection for PSMA in synthetic urine without requiring enzymatic or other amplification.

Indexed as

AlkynesAzidesSulfhydryl CompoundsAntigens, SurfaceBacteriophagesBiomarkers, TumorBiosensing TechniquesCyclizationGlutamate Carboxypeptidase IIHumansLigandsLimit of DetectionMaleModels, MolecularMolecular StructureProstatic NeoplasmsAlkynesAntigens, SurfaceAzidesBiomarkers, TumorFOLH1 protein, humanGlutamate Carboxypeptidase IILigandsSulfhydryl Compounds

Identifiers

PMID23614709
PMCPMC3683571
OpenAlexW1974229936

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.